ArticleComputational and structural biotechnology journal2026
The Abundance of α-Chain-Centric TCRs in the Mouse Repertoire of Primarily Activated Effectors and Reactivated Memory T Cells.
Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chain centricity is a feature of some T cell receptors (TCRs), in which one hemi-chain (α or β) dominates in antigen recognition. The exact proportion of chain-centric TCRs in the native repertoire is currently unknown, as is their inclusion in the repertoires of different functional T cell subsets. Discovering these main issues will elucidate the origin of chain-centric clonotypes and greatly improve their detection in bulk repertoires. In this work, the frequency and abundance of clonotypes with the dominant-active α-chain TCR (TCRα), i.e., α-chain-centric clonotypes, were identified in the mouse repertoires of primarily activated effectors and reactivated memory cells specific to tumor alloantigens. Screening tests in vitro showed that α-chain-centric clonotypes were contained in both repertoires, indicating that α-chain centricity could be an inherent feature of some TCRs. In both repertoires, the proportions of such clonotypes were found to be 20% to 25% of clonotypes expanded during antigenic stimulation. Transduction of naïve T cells with the individual dominant-active TCRα from both repertoires generated cytotoxic effectors that specifically killed the cognate tumor cells in vitro. This study confirmed previous findings that T cell modification with TCRα of α-chain-centric clonotypes generated functionally active antigen-specific effectors. Clonotypes with the dominant-active TCRα were actively involved in the primary allogeneic response. In contrast to primarily activated effectors, α-chain-centric memory clonotypes had the complementarity-determining region 3 (CDR3) with the unique physicochemical signature of shorter length, increased charge, and lower volume and polarity. Here, α-chain-centric memory clonotypes were proposed as promising candidates for adoptive TCR-T cell therapy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.